These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1007 related articles for article (PubMed ID: 27922044)

  • 1. From tumour heterogeneity to advances in precision treatment of colorectal cancer.
    Punt CJ; Koopman M; Vermeulen L
    Nat Rev Clin Oncol; 2017 Apr; 14(4):235-246. PubMed ID: 27922044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer.
    Sinicrope FA; Okamoto K; Kasi PM; Kawakami H
    Clin Gastroenterol Hepatol; 2016 May; 14(5):651-8. PubMed ID: 26872400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
    László L
    Magy Onkol; 2010 Dec; 54(4):383-94. PubMed ID: 21163770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological complete response with anti-PD-1 therapy in a patient with microsatellite instable high, BRAF mutant metastatic colon cancer: a case report and review of literature.
    Sehdev A; Cramer HM; Ibrahim AA; Younger AE; O'Neil BH
    Discov Med; 2016 May; 21(117):341-7. PubMed ID: 27355330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015.
    Price TJ; Thavaneswaran S; Burge M; Segelov E; Haller DG; Punt CJ; Arnold D; Karapetis CS; Tebbutt NC; Pavlakis N; Gibbs P; Shapiro JD
    Expert Rev Anticancer Ther; 2016 May; 16(5):557-71. PubMed ID: 27010906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology.
    Corti G; Bartolini A; Crisafulli G; Novara L; Rospo G; Montone M; Negrino C; Mussolin B; Buscarino M; Isella C; Barault L; Siravegna G; Siena S; Marsoni S; Di Nicolantonio F; Medico E; Bardelli A
    Clin Colorectal Cancer; 2019 Jun; 18(2):91-101.e3. PubMed ID: 30981604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic diversity of colorectal cancer: Changing landscape and emerging targets.
    Ahn DH; Ciombor KK; Mikhail S; Bekaii-Saab T
    World J Gastroenterol; 2016 Jul; 22(25):5668-77. PubMed ID: 27433082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?].
    Cohen R; Cervera P; Svrcek M; Dumont C; Garcia ML; Chibaudel B; de Gramont A; Pocard M; Duval A; Fléjou JF; André T
    Bull Cancer; 2015 Jun; 102(6 Suppl 1):S72-81. PubMed ID: 26118880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer.
    Cohen R; Svrcek M; Dreyer C; Cervera P; Duval A; Pocard M; Fléjou JF; de Gramont A; André T
    Curr Oncol Rep; 2016 Mar; 18(3):18. PubMed ID: 26861657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies.
    Akkad J; Bochum S; Martens UM
    Langenbecks Arch Surg; 2015 Feb; 400(2):129-43. PubMed ID: 25701352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic colorectal cancer: current state and future directions.
    Fakih MG
    J Clin Oncol; 2015 Jun; 33(16):1809-24. PubMed ID: 25918280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting BRAF aberrations in advanced colorectal carcinoma: from bench to bedside.
    Abdel-Rahman O
    Future Oncol; 2016 Jan; 12(1):25-30. PubMed ID: 26616508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent therapeutic advances in the treatment of colorectal cancer.
    Ciombor KK; Wu C; Goldberg RM
    Annu Rev Med; 2015; 66():83-95. PubMed ID: 25341011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor in CRC patients in the era of the RAS.
    Yanmaz MT; Demir G; Erdamar S; Keskin S; Aydin MF; Guner SI
    Hepatogastroenterology; 2015; 62(137):40-4. PubMed ID: 25911864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision medicine for metastatic colorectal cancer: an evolving era.
    Guler I; Askan G; Klostergaard J; Sahin IH
    Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):919-931. PubMed ID: 31475851
    [No Abstract]   [Full Text] [Related]  

  • 18. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized therapy for metastatic colorectal cancer.
    Silvestri A; Pin E; Huijbers A; Pellicani R; Parasido EM; Pierobon M; Petricoin E; Liotta L; Belluco C
    J Intern Med; 2013 Jul; 274(1):1-24. PubMed ID: 23527888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic treatment for metastatic colorectal cancer in the era of precision medicine.
    Sandhu J; Lavingia V; Fakih M
    J Surg Oncol; 2019 Apr; 119(5):564-582. PubMed ID: 30802315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.